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In this issue ofNeuron, Lin et al. (2015) report an optical method to precisely manipulate the activity of GABAA
receptors by designing a mutant receptor that binds photosensitive compounds. This allows for studying
GABAA receptors in situ and represents a valuable tool to investigate how inhibition affects brain physiology.Ensuring that cell excitability in the brain is
controlled, and can form part of a mean-
ingful neural code, is mostly the responsi-
bility of the neurotransmitter GABA and its
associated receptors. GABA is essentially
the conductor of an inhibitory orchestra
formed from interneurons and GABA re-
ceptors, which together cause inhibition
either by rapidly activating anion flux
across the cell membrane (via GABAA
receptors) or by initiating slower se-
cond messenger-mediated signaling (via
GABAB receptors). To investigate how in-
hibition affects brain physiology and how
its dysfunction can precipitate numerous
diseases requires clear mechanistic un-
derstanding. The major investigative tool
usually employed for this purpose is elec-
trophysiology, but in this issue of Neuron,
Lin et al. (2015) describe a new elegant
optical method based on a range of
light-sensitive compounds. When bound
to GABAA receptors, these molecules
can enable the precise temporal and
spatial ‘‘tuning’’ of GABAA receptor activ-
ity following their exposure to light of
specified wavelengths. They are set to
become a valuable addition to the pano-
ply of optical methods that are revolution-
izing our understanding of the nervous
system.
Manipulating the activity of native
GABAA receptors using photochemical
approaches is quite challenging, because
GABAA receptors can show some
inherent sensitivity to UV light (Chang
et al., 2001), and because ligand speci-
ficity is critically important if particular
isoforms of theGABAA receptor are the in-
tended targets. Lin et al. (2015) sought to
confer selectivity by exchanging a residue
near the GABA binding site for cysteine
(Cys). They then constructed a modular-
based compound, termed a photoswitch-
able-tethered-ligand (PTL; Figure 1) thatcould anchor itself to the Cys residue,
and by using light to change the mole-
cule’s conformation, facilitate entry of a
ligand into the GABA binding site (located
at the b-a subunit interface) to manipulate
receptor activity. The PTL has three mod-
ules: a maleimide, which covalently binds
to Cys and creates a highly stable S-C
bond on theGABAA receptor; this is linked
to an azobenzene group, which can flip
between cis and trans states when
exposed to specific wavelengths of
light (the ‘‘photoswitch’’); finally, this is
attached to the third module, a GABAA re-
ceptor ligand, which in this study is usu-
ally a guanidinium derivative of GABA
that binds to the orthosteric (neurotrans-
mitter binding) site of the receptor. Finally,
a repeat methylene spacer ((-CH2-)n,
where n = 1–4) was also included in
some compounds between the azoben-
zene and receptor ligand groups, presum-
ably to increase molecular flexibility for
ligand binding.
The principle underlying the use of PTLs
is that light-induced conformational flip-
ping of the molecule between cis and
trans will change its ability to access and
bind to the GABA binding site. Interest-
ingly, although the PTL binding modules
were all designed to be agonists, they un-
expectedly showed antagonist behavior,
which was also apparent in the authors’
previous study using muscimol (Lin
et al., 2014); nevertheless, they are still
very useful tools for manipulating GABA
receptor activity.
It is often reasonably assumed that li-
gands that target the orthosteric site
should also compete with GABA for bind-
ing. Using recombinant GABAA receptors,
Lin et al. (2015) selected Threonine 125 in
the binding domain for replacement by
Cys (a1T125Cb2g2) and showed a compet-
itive-type displacement of the GABA doseNeuron 88,response curve in the presence of a trans-
PTL, suggesting that the PTL is suffi-
ciently flexible (particularly if there is a
spacer) for the guanidinium-ligand to
bind and dissociate from the orthosteric
site, despite the PTL being tethered by
the maleimide group. The degree of inhi-
bition is quite extensive, reaching ap-
proximately 80% for the most effective
PTL inhibiting half-maximal GABA re-
sponses, though at GABA concentrations
likely to exist at inhibitory synapses
(1–3 mM), competitive inhibition may be
reduced (to 30%).
To explore the usefulness of these tool
compounds for manipulating the activity
of other members of the GABAA receptor
family, the Cys substitution method was
used for a2–a6 subunits for sequential
expression with b2 and g2 subunits. Lin
et al. (2015) relocated the Cys substitution
from that used for a1 subunits, to a posi-
tion that was now within a 4-amino acid
motif considered to be important for
determining the different potencies of
GABA at GABAA receptors containing
different a subunits (Bo¨hme et al., 2004).
Reassuringly, the Cys substitutions main-
tained functional neutrality. Thus, Lin et al.
(2015) had succeeded in creating a highly
useful palette of Cys-substituted GABAA
receptor isoforms that could be differen-
tially regulated by light.
Such a palette enables a number of
interesting experiments to be conducted.
We know that GABAA receptor isoforms
show differential distribution throughout
the brain, even within the membrane do-
mains of a single neuron (soma, dendrites,
axon initial segment; Fritschy and Bru¨nig,
2003). Now we have a means to dissect
their relative subcellular distribution and
explore their relative physiological
function. Lin et al. (2015) addressed
this aspect by expressing two GABAADecember 2, 2015 ª2015 Elsevier Inc. 845
Figure 1. Photo-inhibition of a1T125Cb2g2 GABAA Receptor by a Tethered PTL
(A) PTLs are composed of three linked modules: a cysteine reactive maleimide; a photoswitchable azo-
benzene; and a GABA (guanidinium derivative) ligand.
(B) Homology model of a1b2g2 showing the interfacial GABA binding site with binding loops A (red),
B (blue), and C (orange) from the principal (+) b2 subunit and loops D (cyan), E (purple), and F (green) from
the complementary () a1 subunit. Both a1T125C and the PTL are shown in yellow. (Ba) In this example, the
cis form of the PTL does not enter the GABA binding site; however, when photoswitched by 500 nm light
into the trans isomer (Bb), the ligand-group accesses the binding site displacing GABA and causing in-
hibition. Light at 380 nm reverts the PTL back to its cis form relieving inhibition.
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rons using a1T125C and a5E125C. This
enabled PTLs to manipulate receptors
activated by prior two-photon uncaging of
(trimethylphosphine-caged) GABA. The
relative sensitivities of the PTL-tethered
receptors to the uncaged GABA sug-
gested clustering of a1 subunits in ‘‘hot-
spots,’’ with a5 receptors more evenly
distributed, in accord with their presumed
synaptic (a1) and extra/perisynaptic (a5)
locations (Bru¨nig et al., 2002; Serwanski
et al., 2006).
Lin et al. (2015) extended their study of
light-regulated GABAA receptors to neu-
rons using viral transduction to express
Cys mutant a subunits. In hippocampal
slices expressing a1T125C, light-exposed
tethered PTLs reduced the amplitudes of
evoked inhibitory postsynaptic currents
(eIPSCs) by >50%. A complete block of
synaptic inhibition is unlikely to be
achieved as different isoforms of GABAA
receptors other than those containing a1846 Neuron 88, December 2, 2015 ª2015 Elssubunits will likely underpin synaptic inhi-
bition, and the Cys-maleimide reaction is
unlikely to be 100% complete. This can
make the exact contributions of specific
a subunits to physiological processes
more difficult to assess. Nevertheless,
by exchanging the type of a subunit ex-
pressed in neurons, e.g., extrasynaptic
a5E125C, the diversity of this method was
demonstrated by using light tomanipulate
GABAA receptor activity associated with
tonic inhibition.
Of course, if synaptic (and tonic) inhibi-
tion is to be controlled by light, then it is
important to have reagents that not only
respond to light with fast on-off kinetics,
enabling a high degree of temporal reso-
lution, but also be able to deliver both
PTLs and sufficient light density to deep
lying neurons contained in slices or pre-
sent in vivo. The kinetics of conforma-
tional flipping for the PTLs will be quite
fast (100–200 ms) when exposed to light
and can, by blocking GABAA receptors,evier Inc.cause temporally precise effects on single
action potentials. The thermal ‘‘resting’’
stability expected of the azobenzene is
evident since when either the cis or trans
forms are not exposed to light, they are
stable over 10–30 min, which is extremely
valuable for experimental protocols.
For spatial penetration, particularly for
affecting GABAA receptors in deep lying
neurons, Lin et al. (2015) infused the PTL
into the intact brain by a delivery pipette
before preparing slices. It was notable
that the extent of photoswitching
affecting GABAA receptors declined
when moving from the pial surface of the
slice to deeper lying cells. This is to be ex-
pected, but even so, the method has
impressive penetration with light reaching
approximately 350 mm into the slice, and
presumably this can be further accentu-
ated by using optic fibers to limit light
scattering by the neuronal parenchyma.
Having extended the repertoire of the
PTL approach to tuning synaptic and
tonic inhibition, and demonstrated good
temporal and spatial dynamics to photo-
switching, Lin et al. (2015) tested their
methodology in vivo by expressing Cys
mutant a subunits in intact brain using
viral transduction, and by creating a
knockin mouse line expressing a1T125C
subunits.
By using viruses, mutant GABAA recep-
tors can be expressed deep into neural
tissue and located to identifiable flu-
orophore-expressing neurons (e.g., ge-
netically engineered parvalbumin [PV]
interneurons [INs] expressing tdtomato).
PTLs can also be infused deep into the
brain, and by using two-photon targeted
patch-clamp recording, the spiking profile
of PV INs could be switched from
bursting- to continuous-type firing, when
inhibition of Cys-substituted GABAA re-
ceptors was induced with a photo-
switched PTL or relieved, respectively.
This established the viability of the
method in vivo, but to control for any aber-
rant overexpression of Cys mutant recep-
tors following viral transduction, Lin et al.
(2015) created a global knockin mouse
that replaced native a1 subunits with
a1T125C.
This photoswitch-ready mutant mouse
line only requires the delivery of PTLs to
be able to gate GABAA receptors using
light. Four cell types exhibiting differential
expression patterns for a1 subunits were
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those cell types where a1 subunit
GABAA receptors are dominant or even
the only receptor isoform expressed, pho-
toswitching induced a strong inhibitory
effect on IPSCs, while IPSC photoswitch-
ing was less effective for cells expressing
a1 with other GABAA receptor isoforms
and completely ineffective for cell types
that lacked a1 subunit expression.
Using awake a1T125C-knockin mice, Lin
et al. (2015) show photoswitch-control of
visually evoked spike firing rates as well
as g-oscillations, which effectively
demonstrated the possibility of interro-
gating physiological functions of specific
GABAA receptor isoforms in the nervous
system. If cell-type-specific knockins are
created, this interrogation can proceed
at the single cell level aswell as at the level
of specific neural networks, establishing
the behavior and role of IN subpopula-
tions (Klausberger et al., 2003).
In designing a mutant receptor that
binds photosensitive compounds, Lin
et al. (2015) have created a very powerful
set of tools for studying GABAA receptors
in situ. These tools need validation against
a set of controls and Lin et al. (2015) have
been very thorough in this regard, testing
the PTLs against other membrane pro-
teins. However, any free surface-exposed
Cys residue will in principle bind the mal-
eimide group of the PTL. For GABAA re-
ceptor subunit, there are relatively few
‘‘free’’ Cys residues in the extracellulardomain (ECD). Two Cys residues are
engaged in a Cys-Cys bond, forming the
Cys loop that characterizes many of the
receptors in the pentameric ligand-gated
ion channel family; so they are presum-
ably unavailable to bind maleimide.
Another potential neurotransmitter recep-
tor that is worth screening is the inhibitory
glycine receptor. It does have 5 Cys resi-
dues in the ECD, four of which may form
two Cys-Cys bonds, leaving one possibly
free for interaction with maleimide.
An interesting aspect of this study is
that the PTLs exhibit antagonist proper-
ties, which is very useful for inhibiting
GABAA receptor activity; however, it
would also be valuable to be able to acti-
vate or positively modulate GABAA recep-
tor function as reported for native GABAA
receptors using an azobenzene-based
propofol derivative (Yue et al., 2012).
Possibly this is easier to achieve from an
allosteric site rather than the orthosteric
site, since Lin et al. (2015) note the
removal of the negatively charged
carboxyl on the guanidinium moiety
seems to prevent agonist activity.
The direction of travel adopted by Lin
et al. (2015)’s study opens many new
investigative possibilities for probing the
role of GABAA receptors in neural circuit
behavior. The need to express mutant
GABAA receptors in neurons seems a
small ‘‘price to pay’’ for the experimental
diversity that becomes available from us-
ing PTLs, though ultimately trying toNeuron 88,emulate these experiments with native
GABAA receptors and other modular-
based compounds remains a challenge
(Mortensen et al., 2014).REFERENCES
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